Possibilities of paliative treatment of ovarial tumour
Authors:
J. Šula; J. Chovanec; L. Minář
Published in:
Prakt Gyn 2008; 12(4): 226-228
Overview
Authors report the case of a woman with diagnosed ovarian tumor and massive ascites. Patient’s respirati on and body movement is seri ously limited by collecti on of fluid in abdominal cavity. Considering age and status of patient making surgery, curative and palliative chemotherapy impossible, a palliative tre atment was chosen. This work reports a long time management of ascites by me ans of large volume paracenthesis.
Key words:
ovarium – cancer – ascites – paracenthesis
Sources
1. Goff BA, Mandel LS, Melancon CH, Muntz HG. Frequency of symptoms of ovarian cancer in women presenting to primary care clinics. JAMA 2004; 291(22): 2705– 2712.
2. Robová H, Rob L, Pluta M et al. Zhoubné nádory ovaria. Moderní Gynek 2000; 9(4): 634– 639.
3. Puiffe ML, Le Page C, Filali- Mouhim A, Zietarska M, Ouellet V, Tonin PN, Chevrette M, Provencher DM, Mes- Masson AM. Characterizati on of ovarian cancer ascites on cell invasi on, proliferati on, sphero id formati on, and gene expressi on in an in vitro model of epithelial ovarian cancer. Neoplasia 2007; 9(10): 820– 829.
4. Oettinger N. Die Militärischen Eide der Hethiter. Wiesbaden 1976.
5. Warrell DA, Cox TN, Firth JD, Benz ED. Oxford textbo ok of medicine. Oxford: Oxford University Press 2003.
6. Runyon BA, Montano AA, Akriviadis EA, Antillon MR, Irving MA, McHutchison JG. The serum- ascites albumin gradient is superi or to the exudate- transudate concept in the differential diagnosis of ascites. Ann Intern Med 1992; 117: 215– 220.
7. Gatta A, Angeli P, Caregaro L, Menon F, Sacerdoti D, Merkel C. A pathophysi ological interpretati on of unresponsiveness to spironolactone in a stepped- care appro ach to the diuretic tre atment of ascites in nonazotemic cirrhotic patients. Hepatology 1991; 14(2): 231– 236.
8. Fogel MR, Sawhney VK, Ne al EA, Miller RG, Knauer CM, Gregory PB. Diuresis in the ascitic patient: a randomized controlled trial of three regimens. J Clin Gastroenterol 1981; 3 (Suppl 1): 73– 80.
9. Runyon BA. Care of patients with ascites. N Engl J Med 1994; 330 (5): 337– 342.
10. Brodanová M, Klener P. Moderní terapie ascitu u jaterní cirhózy. Vnitr Lek 1994; 40(11): 739– 744.
11. Ptácková B, Kopecný J, Zatocil P, Anton M. Intraperitone ální podání vysokých dávek cisplatiny u pokročilého nádoru ovaria. Cesk Gynekol 1989; 54(2): 106– 109.
12. Sláma O, Vorlícek J. Nevyléčitelný onkologický pacient? Vnitr Lek 2001; 47(8): 588– 590.
Labels
Paediatric gynaecology Gynaecology and obstetrics Reproduction medicineArticle was published in
Practical Gynecology
![Issue 4](https://www.prolekare.cz/media/cache/resolve/journal_issue/media/image_pdf/8284841a85e7735466ea9339962ff230.jpeg)
2008 Issue 4
Most read in this issue
- Bacterial vaginosis and the role of vaginal acidification
- Factors influencing vaginal eumicrobia
- Identification of proliferation markers in endometrial carcinoma
- Possibilities of paliative treatment of ovarial tumour